Clozapine Is the Most Effective Antipsychotic Medication: Why Are We Not Prescribing It?

Credit Available

* You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.

In this presentation, Dr. Olaoluwa Okusaga discusses the clinical reasoning that supports strategies to increase the utilization of clozapine to treat treatment-resistant schizophrenia.
This Menninger Department of Psychiatry and Behavioral Sciences Grand Rounds session will take place on Wednesday, November 29, 2023 at 12:00 p.m. Attendance for this session will be available in-person, and remotely through Zoom.

Activity Information

How to Claim Credit

You may claim credit after watching this activity.

You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.

Needs Statement

Psychiatrists, psychologists, psychiatric nurses, social workers, and healthcare professionals in related disciplines need to receive regular updates on advances in neuroscience, psychiatric research, psychotherapy, and the evolving best practices for evaluating, diagnosing, and treating psychiatric disorders. The series aims to improve clinical practice through critical appraisal of psychiatric research, the use of evidence-based treatment approaches, and the integration of multiple treatment modalities to enhance the quality of psychiatric care and improve patient outcomes.

Educational Objectives

At the conclusion of the session, the participants should be able to:

  • Review the morbidity and mortality rates associated with treatment-resistant schizophrenia (TRS).
  • List the reasons why psychiatrists are reluctant to prescribe clozapine despite its proven effectiveness in patients with TRS.
  • Compare and contrast various antipsychotic medications and the effects they can have on a patient with TRS.
  • Discuss how the risk of clozapine-induced neutropenia changes with time.
  • Develop a strategy to implement prescribing clozapine to a patient with TRS.

Target Audience

Professional Categories

  • Physicians
  • Medical Students
  • Fellows
  • Nurses
  • Other Health Professionals

Specialties

  • Psychiatry

Interest Groups

Activity Evaluation

Evaluation by questionnaire will address program content, presentation, and possible bias.

Educational Methods

  • Lectures

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Social Work: The Baylor College of Medicine Division of Continuing Professional Development (License Number 7270) is an approved continuing education provider for Social Workers through the Texas State Board of Social Worker Examiners. This activity has been approved for 0.75 continuing education unit.

Activity Director

  1. Kim-Lan Tran Czelusta, M.D.

    Kim-Lan Tran Czelusta, M.D.

    Vice Chair for Education, Brown Foundation Chair in Psychiatric Education in the Department of Psychiatry and Behavioral Sciences
    Baylor College of Medicine

Term of Approval

November 1, 2023 through November 30, 2025. Original release date: November 1, 2023.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Olaoluwa Okusaga, M.D.

    Olaoluwa Okusaga, M.D.

    Associate Professor of Psychiatry and Behavioral Sciences
    Baylor College of Medicine, Michael E. DeBakey VA Medical Center

    Disclosure:

    Nothing to disclose.

Activity Director

  1. Kim-Lan Tran Czelusta, M.D.

    Kim-Lan Tran Czelusta, M.D.

    Vice Chair for Education, Brown Foundation Chair in Psychiatric Education in the Department of Psychiatry and Behavioral Sciences
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Planning Committee Members

  1. Kim-Lan Tran Czelusta, M.D.

    Kim-Lan Tran Czelusta, M.D.

    Vice Chair for Education, Brown Foundation Chair in Psychiatric Education in the Department of Psychiatry and Behavioral Sciences
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Mauro A. Garcia-Altieri, M.D. Placeholder Image

    Mauro A. Garcia-Altieri, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. Jennifer R. Gatchel, M.D., Ph.D.

    Jennifer R. Gatchel, M.D., Ph.D.

    Associate Professor
    Baylor College of Medicine, Michael E. DeBakey VA Medical Center

    Disclosure:

    Nothing to disclose.

  4. Lauren Havel, M.D. Placeholder Image

    Lauren Havel, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  5. Ashley W. LeMaire, Ph.D. Placeholder Image

    Ashley W. LeMaire, Ph.D.

    Assistant Professor
    Baylor College of Medicine, Menninger Clinic

    Disclosure:

    Nothing to disclose.

  6. Adeolu O. Oladunjoye, M.B.Ch.B., M.P.H.

    Adeolu O. Oladunjoye, M.B.Ch.B., M.P.H.

    Psychiatry and Behavioral Sciences Resident
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  7. Patrick O'Malley, M.D. Placeholder Image

    Patrick O'Malley, M.D.

    Assistant Professor
    Baylor College of Medicine, Texas Children's Hospital

    Disclosure:

    Nothing to disclose.

  8. Lindsey S. Pershern, M.D.

    Lindsey S. Pershern, M.D.

    Associate Professor of Psychiatry and Behavioral Sciences
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  9. Jose Ribas Roca, M.D.

    Jose Ribas Roca, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  10. Shelley Rote, M.D. Placeholder Image

    Shelley Rote, M.D.

    Psychiatry and Behavioral Sciences Resident
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  11. Kerala Ria Saugh, M.D. Placeholder Image

    Kerala Ria Saugh, M.D.

    Child and Adolescent Psychiatry Fellow
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  12. John Saunders, M.D., M.S.

    John Saunders, M.D., M.S.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  13. Asim A. Shah, M.D.

    Asim A. Shah, M.D.

    Barbara & Corbin Robertson Jr. Endowed Chair in Psychiatry
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  14. Daryl Shorter, M.D.

    Daryl Shorter, M.D.

    Associate Professor, Medical Director of Addiction Services
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Presenter:

Olaoluwa Okusaga, M.D.

Olaoluwa Okusaga, M.D.

Associate Professor of Psychiatry and Behavioral Sciences Baylor College of Medicine, Michael E. DeBakey VA Medical Center

Health Topics

You May Also Be Interested In

On Demand
Baylor College of Medicine Menninger Department of Psychiatry and Behavioral Sciences Grand Rounds
Activity duration: 1 hr
Activity Available On Demand
Credit 1.00 Continuing Medical Education Credits Available
On Demand
Baylor College of Medicine Menninger Department of Psychiatry and Behavioral Sciences Grand Rounds
Activity duration: 1 hr
Activity Available On Demand
Credit 1.00 Continuing Medical Education Credits Available
On Demand
Baylor College of Medicine Menninger Department of Psychiatry and Behavioral Sciences Grand Rounds
Activity duration: 1 hr
Activity Available On Demand
Credit 1.00 Continuing Medical Education Credits Available